This investigate was performed to evaluate the probable in the CPPs with tumor-targeting Qualities to provide a cytotoxic payload to HCC cells. We explored employing a CXCR4-focusing on peptide, T22, fused with cytotoxic peptide PE24, to be a novel therapeutic tactic for CXCR4+ HCC cells. T22 was chosen since the https://spencerzytoh.actoblog.com/32058989/detailed-notes-on-https-1433129-com